<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39474447</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Effect of Universal Masking on Non-Severe Acute Respiratory Syndrome Coronavirus 2 Healthcare-Associated Respiratory Viral Infections.</ArticleTitle><Pagination><StartPage>ofae617</StartPage><MedlinePgn>ofae617</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofae617</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofae617</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Respiratory viral infections are common and are a major cause of morbidity and mortality. We evaluated the impact of universal masking implemented during the coronavirus disease 2019 (COVID-19) pandemic on other healthcare-associated respiratory viral infections (HA-RIs) in an academic medical center.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective cohort study was performed among all inpatients aged ≥18 years admitted between 1 May 2019 and 30 June 2022. Universal masking was implemented in May 2020 at our hospital and state-level mask mandates had been lifted by May 2021. We evaluated and compared the HA-RI rates, adjusted for monthly community-onset viral infections, during the premasking period, universal masking period, and post-community mandate period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We identified 3015 patients (median age, 58 years; 48.0% males) with a positive respiratory viral test within 14 days prior to, or during, their hospitalization; 441 (14.6%) patients had an HA-RI. Rhinovirus/enterovirus (51.0%), parainfluenza virus (14.3%), coronaviruses (229E, OC43, HKU1, and NL63; 13.2%) and influenza (10.0%) were the predominant HA-RI viruses detected. The monthly HA-RI rate decreased 34.9% (95% confidence interval, 8.8%-51.8%) after the implementation of universal masking (0.71 premasking period vs 0.19 universal masking period vs 0.35 infections per 1000 patient-days in the post-community mandate period) while accounting for a drop in the community-onset respiratory viral infections using a structural time-series model analysis (<i>P</i> &lt; .001), with no significant change in HA-RI rates with the relaxation of community masking mandate.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Implementation of universal masking at our hospital was associated with a significantly reduced incidence of HA-RIs.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Munigala</LastName><ForeName>Satish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ching</LastName><ForeName>Patrick R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0001-6106-2799</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hospital Epidemiology and Infection Prevention, Barnes-Jewish Hospital, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waken</LastName><ForeName>R J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hospital Epidemiology and Infection Prevention, Barnes-Jewish Hospital, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasama</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Hospital Epidemiology and Infection Prevention, Barnes-Jewish Hospital, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hospital Epidemiology and Infection Prevention, Barnes-Jewish Hospital, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yarbrough</LastName><ForeName>Melanie L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-2166-7552</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warren</LastName><ForeName>David K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">healthcare setting</Keyword><Keyword MajorTopicYN="N">healthcare-associated respiratory viral infections</Keyword><Keyword MajorTopicYN="N">medical face mask</Keyword><Keyword MajorTopicYN="N">respiratory viral infections</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. All authors: No potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>30</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>30</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>30</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39474447</ArticleId><ArticleId IdType="pmc">PMC11521325</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofae617</ArticleId><ArticleId IdType="pii">ofae617</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jin  X, Ren  J, Li  R, et al.  Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. EClinicalMedicine  2021; 37:100986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343248</ArticleId><ArticleId IdType="pubmed">34386754</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow  EJ, Mermel  LA. Hospital-acquired respiratory viral infections: incidence, morbidity, and mortality in pediatric and adult patients. Open Forum Infect Dis  2017; 4:ofx006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5414085</ArticleId><ArticleId IdType="pubmed">28480279</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner  RB. Nosocomial viral respiratory infections. Clin Microbiol Newsl  1994; 16:81–5.</Citation></Reference><Reference><Citation>Sung  AD, Sung  JAM, Thomas  S, et al.  Universal mask usage for reduction of respiratory viral infections after stem cell transplant: a prospective trial. Clin Infect Dis  2016; 63:999–1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5036914</ArticleId><ArticleId IdType="pubmed">27481873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol  KA, De la Vega-Diaz  I, Edmondson-Martin  K, et al.  Masks for prevention of respiratory viruses on the BMT unit: results of a quality initiative. Transpl Infect Dis  2016; 18:965–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27632416</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidelman  JL, Lewis  SS, Advani  SD, et al.  Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve. Infect Control Hosp Epidemiol  2020; 41:1466–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7520637</ArticleId><ArticleId IdType="pubmed">32576336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang  X, Ferro  EG, Zhou  G, Hashimoto  D, Bhatt  DL. Association between universal masking in a health care system and SARS-CoV-2 positivity among health care workers. JAMA  2020; 324:703–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362190</ArticleId><ArticleId IdType="pubmed">32663246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong  S-C, Lam  GK-M, AuYeung  CH-Y, et al.  Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: implication of universal masking in hospitals. Infect Control Hosp Epidemiol  2021; 42:218–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7468684</ArticleId><ArticleId IdType="pubmed">32799965</ArticleId></ArticleIdList></Reference><Reference><Citation>

Siegel  JD, Rhinehart  E, Jackson  M, Chiarello  L; Healthcare Infection Control Practices Advisory Committee . 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Available at: https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html. Accessed 24 June 2024.</Citation></Reference><Reference><Citation>
St Louis County Department of Public Health . Public health orders. 2022. Available at: https://stlouiscountymo.gov/st-louis-county-departments/public-health/covid-19/public-health-orders/. Accessed 24 June 2024.</Citation></Reference><Reference><Citation>Chou  R, Dana  T, Jungbauer  R, Weeks  C, McDonagh  MS. Masks for prevention of respiratory virus infections, including SARS-CoV-2, in health care and community settings: a living rapid review. Ann Intern Med  2020; 173:542–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322812</ArticleId><ArticleId IdType="pubmed">32579379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee  LEI, Conceicao  EP, Tan  JY, et al.  Unintended consequences of infection prevention and control measures during COVID-19 pandemic. Am J Infect Control  2021; 49:469–77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610096</ArticleId><ArticleId IdType="pubmed">33157180</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidelman  JL, DiBiase  L, Kalu  IC, et al.  The impact of a comprehensive coronavirus disease 2019 (COVID-19) infection prevention bundle on non-COVID-19 hospital-acquired respiratory viral infection (HA-RVI) rates. Infect Control Hosp Epidemiol  2023; 44:1022–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">35652146</ArticleId></ArticleIdList></Reference><Reference><Citation>Solberg  RB, Fretheim  A, Elgersma  IH, et al.  Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial. BMJ  2024; 386:e078918. Erratum in: BMJ 2024; 386:q1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11267995</ArticleId><ArticleId IdType="pubmed">39048132</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh  T, MacIntyre  CR, Baker  MG, et al.  Masks and respirators for prevention of respiratory infections: a state of the science review. Clin Microbiol Rev  2024; 37:e0012423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11326136</ArticleId><ArticleId IdType="pubmed">38775460</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention . 2024 National Healthcare Safety Network (NHSN) patient safety component manual. Chapter 2. Identifying healthcare-associated infections. 2024. Available at: https://www.cdc.gov/nhsn/pdfs/pscmanual/2psc_identifyinghais_nhsncurrent.pdf. Accessed 15 September 2024.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>